All Pharma News
Biosplice searches for a path forward osteoarthritis drug fails late-stage study

Biosplice searches for a path forward osteoarthritis drug fails late-stage study
Jared Whitlock ENDPTS
22 Apr 2024
Share Share
Biosplice: OA-07 P3 Lorecivivint Data At OARSI, OA-21 12-Wk Results

Biosplice: OA-07 P3 Lorecivivint Data At OARSI, OA-21 12-Wk Results
GLOBENEWSWIRE
18 Apr 2024
Share Share
Biosplice Therapeutics Announces Department of Defense (DoD) Award

Biosplice Therapeutics Announces Department of Defense (DoD) Award
GLOBENEWSWIRE
08 Mar 2024
Share Share
Biosplice announces data from phase 3 trial in knee osteoarthritis

Biosplice announces data from phase 3 trial in knee osteoarthritis
PHARMABIZ
17 Dec 2022
Share Share
Biosplice Announces Data from Phase 3 Trial in Knee Osteoarthritis

Biosplice Announces Data from Phase 3 Trial in Knee Osteoarthritis
GLOBENEWSWIRE
15 Dec 2022
Share Share
Biosplice Announces Data from Recent Trials in Knee Osteoarthritis Ph 3 Trial

Biosplice Announces Data from Recent Trials in Knee Osteoarthritis Ph 3 Trial
GLOBENEWSWIRE
11 Nov 2022
Share Share
Biosplice Therapeutics Announced New Clinical Data for Cirtuvivint (SM08502)

Biosplice Therapeutics Announced New Clinical Data for Cirtuvivint (SM08502)
GLOBENEWSWIRE
29 Sep 2022
Share Share
$12B biotech Biosplice lays off 41, axes hair loss asset

$12B biotech Biosplice lays off 41, axes hair loss asset
K. LaHucik FIERCEBIOTECH
09 Feb 2022
Share Share
First Subject Dosed in Biosplice Therapeutics Phase 1b Clinical Trial

First Subject Dosed in Biosplice Therapeutics Phase 1b Clinical Trial
GLOBENEWSWIRE
17 Nov 2021
Share Share
Biosplice Licenses Rights for Lorecivivint to Haisco for China

Biosplice Licenses Rights for Lorecivivint to Haisco for China
GLOBENEWSWIRE
15 Sep 2021
Share Share